UK markets open in 6 hours 11 minutes

Axonics, Inc. (AXNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
66.64+0.17 (+0.26%)
At close: 04:00PM EDT
66.64 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close66.47
Open66.50
Bid47.55 x 200
Ask85.61 x 200
Day's range66.50 - 66.78
52-week range47.59 - 69.68
Volume390,400
Avg. volume913,987
Market cap3.399B
Beta (5Y monthly)0.59
PE ratio (TTM)N/A
EPS (TTM)-0.12
Earnings date29 Apr 2024 - 03 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est71.73
  • PR Newswire

    Boston Scientific Announces Results for First Quarter 2024

    Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $495 million or $0.33 per share (EPS), compared to $300 million or $0.21 per share a year ago, and achieved adjusted3 EPS of $0.56 for

  • Zacks

    All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy

    Axonics (AXNX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  • Business Wire

    Axonics Stockholders Approve Merger Agreement with Boston Scientific

    IRVINE, Calif., March 22, 2024--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics’ merger agreement with Boston Scientific Corporation (NYSE: BSX). According to preliminary voting results from the special meeting of stockholders held earlier today, a majority of the shares of Axonics’ common stock outstanding and entitled to vote at the special meeting voted in favor of adopting the merger agreement. Final voting results, as tabulated by an independen